TRANSCRIPT ID 4370 I 100924: Brian Rini - ESMO 2024 - Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan Versus Everolimus in Participants with Previously Treated Advanced Clear Cell Renal Cell Carcinoma